Health Secretary Robert F. Kennedy Jr.’s newly appointed vaccine advisers on Friday weighed whether to recommend this fall’s COVID-19 shots, as confusion and limited access continue to frustrate patients nationwide. The panel’s debate follows recent FDA restrictions reserving the updated vaccines for older adults and high-risk groups, raising questions about equity and insurance coverage.
The CDC’s Advisory Committee on Immunization Practices — now stocked with members skeptical of past coronavirus policies — has yet to decide whether to endorse broader access or impose further limits.
This story is breaking; more to follow.